Clinical Trials Sponsored by ZabBio Inc.

Total 35666 results

NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
Fabio Correia Sampaio

Completed

In Vivo Evaluation of an Experimental Fluoride-containing Dentifrice With Hydrocolloid (FdentifriceT)

Dental Caries

Brazil
Fabio Correia Sampaio

Completed

Evaluation in Vivo of Mouthwash With Nanoencapsulated Fluoride

Dental Caries

Brazil
Fabio Savorgnan
Mallinckrodt

Withdrawn

Nitric Oxide During CPB to Reduce AKI in Neonates

Acute Kidney Injury | Congenital Heart Disease

United States
Fabio Correia Sampaio

Unknown

Evaluation in Vivo of Dentifrice With Nanoencapsulated Fluoride

Dental Caries

Brazil
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
London School of Hygiene and Tropical Medicine
Centre for Infectious Disease Research in Zambia

Completed

Sanitation Demand Creation in Peri-Urban Slums of Lusaka, Zambia (SanDem)

Diarrhea

Zambia
Mulungushi University
Vanderbilt University Medical Center; University of Zambia

Completed

HIV, Immune Activation and Salt Sensitive Hypertension (HISH)

HIV-1-infection | Hypertension,Essential

Zambia
FHI 360
Ghana Health Services; Ministry of Health, Zambia

Completed

Increasing Family Planning Uptake Among Postpartum Women

Postpartum Period

Ghana, Zambia
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI); University of Alabama at... and other collaborators

Completed

Task-shifted Adaptation of the WHO-PEN Intervention to Address Cardio-metabolic Complications in People Living With HIV in Zambia (TASKPEN)

HIV | Non Communicable Diseases

Zambia
University of Alabama at Birmingham
Columbia University; Centre for Infectious Disease Research in Zambia

Recruiting

Common Elements Treatment Approach HIV Alcohol Reduction Trial in Zambia (CHARTZ)

Alcohol-Related Disorders | HIV/AIDS | Mental Illness

Zambia
University of Alabama at Birmingham
Centre for Infectious Disease Research in Zambia; Chiesi Foundation

Completed

Impact of Hindmilk on Weight Gain Among Moderate to Very Preterm Infants in Zambia

Postnatal Growth Restriction

Zambia
University of Colorado, Denver
University Teaching Hospital, Lusaka, Zambia; HarvestPlus

Completed

Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months (HPZM)

Nutritional Deficiency

United States, Zambia
Institute of Tropical Medicine, Belgium
Tropical Diseases Research Centre, Zambia

Terminated

Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy

Malaria in Pregnancy

Zambia
University of Alabama at Birmingham
University Teaching Hospital, Lusaka, Zambia

Completed

Kangaroo Mother Care With Plastic Bag (Trials 2A & 2B)

Preterm Infant | Hypothermia Neonatal

Zambia
Institute of Tropical Medicine, Belgium
Tropical Diseases Research Centre, Zambia

Completed

Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy

HIV Infections | Malaria in Pregnancy

Zambia
University of Alabama at Birmingham
University Teaching Hospital, Lusaka, Zambia

Completed

Feasibility, Acceptability, and Safety of Neonatal Male Circumcision in Lusaka, Zambia

Neonatal Male Circumcision

Zambia
London School of Hygiene and Tropical Medicine
University of Zambia

Unknown

Trial of Safe Water Storage Among People Living With HIV

Diarrhea | HIV | Waterborne Disease

Zambia
University of Bern
Centre for Infectious Disease Research in Zambia; Lighthouse Trust; University...

Completed

The DTG-SWITCH Study: Longitudinal Analysis of Virologic Failure and Drug Resistance at and After Switching to Dolutegravir-based First-line ART (DTG-SWITCH)

Hiv | Drug Resistancy | Virologic Failure

Malawi, Zambia
University of Alabama at Birmingham
University of Bern; Centre for Infectious Disease Research in Zambia

Completed

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa

HIV | Antiretroviral Therapy | Alcohol Use Disorder | Liver Fibrosis | Hepatitis B Virus | Africa

Zambia
Centre for Infectious Disease Research in Zambia
Imperial College London; Christian Medical College, Vellore, India

Completed

Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model

Diarrhoeal Disease

Zambia
Centre for Infectious Disease Research in Zambia
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Causes of Rotavirus Vaccine Failure in Zambian Children

Diarrhoea

Zambia
Fabio Iwamoto, MD
Bristol-Myers Squibb

Active, not recruiting

Nivolumab for Recurrent or Progressive IDH Mutant Gliomas

Gliomas

United States
Fabio lucas rodrigues

Completed

Open Tibia Fractures a Comparative Study Between Biplane External Fixator and Locked Intramedullary Nail

Open tíbia Fracture
University of Alabama at Birmingham
University Teaching Hospital, Lusaka, Zambia

Withdrawn

Kangaroo Mother Care With Plastic Bag (Trials 1A & 1B)

Preterm Birth | Hypothermia, Newborn

Zambia
University of Alabama at Birmingham
Centre for Infectious Disease Research in Zambia; University Teaching Hospital

Completed

HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia (COLAH)

Hiv

Zambia
PATH
Centers for Disease Control and Prevention; Ministry of Health, Zambia

Recruiting

Proactive Community Case Management for Malaria in Zambia (ProACT)

Malaria | Malaria, Falciparum

Zambia
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
Prof. Facchinetti Fabio

Completed

Procalcitonin in Cirrhotic Patients at High Risk for Sepsis

Sepsis | Cirrhosis | Ascites

Italy
Emory University
International AIDS Vaccine Initiative; Zambia-Emory HIV Research Project

Completed

Zambia SiVET MMR Tdap-IPV (SiVET)

High Risk for HIV

Zambia
FHI 360
Bill and Melinda Gates Foundation; Ministry of Health, Zambia

Completed

Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia

Male Circumcision

Zambia
Henrik Gudbergsen
Rigshospitalet, Denmark; The DANBIO registry, Denmark

Completed

Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis (PRO)

Rheumatoid Arthritis | Axial Spondyloarthritis
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States
Prof. Facchinetti Fabio

Completed

Hepatocellular Carcinoma Growth and Molecular Aggressiveness (UniRer)

Hepatocellular Carcinoma | Cirrhosis

Italy
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Recruiting

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

United States
Mukuba University
University of Zambia; National Science and Technology Council; Afe Babalola University... and other collaborators

Not yet recruiting

Overweight and Obesity in Relation to Type ll Diabetes Melitus

Diabetes Mellitus, Type 2 | Overweight and Obesity

Zambia
Novan, Inc.
Synteract, Inc.; Therapeutics, Inc.

Completed

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study (B-SIMPLE4)

Molluscum Contagiosum

United States
Centre for Infectious Disease Research in Zambia
London School of Hygiene and Tropical Medicine; Unilever R&D

Completed

Generic Behavioural Change Campaign for COVID-19 Prevention

Evaluation Study

Zambia
OBELAB, Inc.
Helptrial Inc.

Not yet recruiting

Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Acute Ischemic Stroke Patients

Korea, Republic of
Athersys, Inc
Medpace, Inc.

Recruiting

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)

Ischemic Stroke

United States, Taiwan
89bio, Inc.
ProSciento, Inc.

Completed

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

NASH

United States, Puerto Rico
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
Eisai Inc.
Quintiles, Inc.

Terminated

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

United States, Australia, Russian Federation, India, Ukraine

Clinical Trials Sponsored by ZabBio Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations